
Panlore 40 Tablet
Marketer
Hublore Healthcare Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Panlore 40 Tablet
Gastric acid production is suppressed by the medication Panlore 40 Tablet, which treats stomach and intestinal conditions linked to excess acidity. These include heartburn, acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering both symptom relief and healing. It's also employed as a preventative measure against stomach ulcers and hyperacidity often associated with prolonged nonsteroidal anti-inflammatory drug use. Classified as a proton pump inhibitor (PPI), Panlore 40 Tablet should be ingested one hour prior to meals, ideally in the morning. Dosage is individualized based on the patient's condition and response. Continued use as prescribed is crucial, even with rapid symptom resolution. Dietary modifications, such as smaller, more frequent meals, and avoidance of caffeine, spicy foods, and fatty foods, can enhance therapeutic efficacy. Common, typically mild, side effects may include nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal discomfort. Persistent or bothersome side effects necessitate medical consultation. Extended use increases the potential for adverse events; prolonged use (exceeding one year) may elevate the risk of fractures, particularly at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your physician. Prior to commencing treatment, inform your doctor of any severe liver dysfunction, concomitant HIV medication use, prior allergic reactions to similar drugs, or pre-existing osteoporosis. Pregnant or lactating individuals should seek medical advice before using Panlore 40 Tablet.
Primary Ingredients of Panlore 40 Tablet
There is no text provided to rephrase.
Uses of Panlore 40 Tablet
Managing heartburn, gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Panlore 40 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Panlore 40 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Panlore 40 Tablet:
- Diarrhea
- Flatulence
- Headache
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Upper respiratory tract infection
How to use Panlore 40 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Panlore 40 Tablet on an empty stomach.
How Panlore 40 Tablet works:
Panlore 40mg tablets function as a proton pump inhibitor, decreasing stomach acid production to alleviate heartburn and acid indigestion symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Combining Panlore 40 Tablet and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Panlore 40 Tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Employing Panlore 40 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Panlore 40 Tablet.
KidneySAFE IF PRESCRIBED
Panlore 40 Tablet poses no safety concerns for patients with kidney impairment; dose modification is unnecessary.
LiverCAUTION
Patients with severe hepatic impairment should use Panlore 40 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Panlore 40 Tablet :
Should you forget a Panlore 40 Tablet dose, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Panlore 40 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Active Class | Gastric acid suppressants |
